IFN-γ can downregulate the expression of two subunits of the glutamate-cystine antiporter on the surface of tumor cells, namely, solute carrier family 3 member 2 (SLC3A2) and SLC7A11, thereby inhibiting tumors. This evidence concerns the gene IFNG and neoplasm.